Triflupromazine
Back to searchMolecule Structure
Scientific Name
Triflupromazine
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00508
http://www.drugbank.ca/drugs/DB00508
Brand Name(s)
Fluopromazine, Nivoman, Vesprin, Vetame
Company Owner(s)
Apothecon Inc Div Bristol Myers Squibb, Bristol Myers Squibb Co, Apothecon Sub Bristol Myers Squibb Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL44085 | ||
PharmGKB | PA451773 | ||
Human Metabolome Database | HMDB0014650 | ||
DrugBank | DB00508 | ||
PubChem: Thomson Pharma | 14925496 | ||
PubChem | 5568 | ||
Mcule | MCULE-9151902507 | ||
LINCS | LSM-3421 | ||
Nikkaji | J2.957B | ||
BindingDB | 67544 | ||
EPA CompTox Dashboard | DTXSID9023704 | ||
DrugCentral | 2742 | ||
Brenda | 6695 | 151912 | 142792 |
Guide to Pharmacology | 4330 | ||
rxnorm | TRIFLUPROMAZINE | TRIFLUPROMAZINE HYDROCHLORIDE | |
ChEBI | 9711 | ||
ZINC | ZINC000000538507 |